Profiel
Neil David Murray was the founder of Redx Pharma Plc, where he served as the Chief Executive Officer & Executive Director from 2010 to 2017.
He is also the founder of PharmEcosse Ltd.
In addition to his founding positions, Dr. Murray held former positions as Director-Chemical Development at Ligand UK Ltd., Director-External Projects at Glaxo Wellcome CA, Director-Business Development at Sigma-Aldrich Fine Chemicals, Principal at Solutia, Inc., and Founding Partner at Essential Science Ltd.
from 2000 to 2012.
Eerdere bekende functies van Neil David Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| REDX PHARMA PLC | Oprichter | 06-11-2017 |
| Essential Science Ltd. | Corporate Officer/Principal | - |
| Glaxo Wellcome CA | Corporate Officer/Principal | - |
| Sigma-Aldrich Fine Chemicals | Corporate Officer/Principal | - |
| VERNALIS | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REDX PHARMA PLC | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
| Essential Science Ltd. | |
| PharmEcosse Ltd. | |
Solutia, Inc.
 Solutia, Inc. Chemicals: Major DiversifiedProcess Industries Solutia, Inc. manufactures performance materials and specialty chemicals. The company was founded in April 1997 and is headquartered in St. Louis, MO. | Process Industries |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| Sigma-Aldrich Fine Chemicals | |
| Glaxo Wellcome CA |
